NIAGEN BIOSCIENCE, INC. Research and Development Expense
NIAGEN BIOSCIENCE, INC. (NAGE) reported Research and Development Expense of $1.51 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-04
- NIAGEN BIOSCIENCE, INC. research and development expense for the quarter ending 2026-06-30 was $1.51M, a 3.45% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. research and development expense for the quarter ending 2026-03-31 was $1.48M, a 17.73% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. research and development expense for the quarter ending 2025-12-31 was $1.71M, a 30.04% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. research and development expense for the quarter ending 2025-09-30 was $1.79M, a 39.15% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. research and development expense for fiscal 2025 was $6.33M, a 5.22% increase from fiscal 2024.
- NIAGEN BIOSCIENCE, INC. research and development expense for fiscal 2024 was $6.02M, a 21.34% increase from fiscal 2023.
- NIAGEN BIOSCIENCE, INC. research and development expense for fiscal 2023 was $4.96M, a 2.74% increase from fiscal 2022.
- NIAGEN BIOSCIENCE, INC. research and development expense for fiscal 2022 was $4.83M, a 25.94% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.51M 10-Q · filed 2026-08-04 | $2.99M 10-Q · filed 2026-08-04 | $4.70M derived: sum of 3 quarters · filed 2026-08-04 | $6.50M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $1.48M 10-Q · filed 2026-05-06 | $3.19M derived: sum of 2 quarters · filed 2026-05-06 | $4.99M derived: sum of 3 quarters · filed 2026-05-06 | $6.55M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $3.50M derived: sum of 2 quarters · filed 2026-03-04 | $5.07M derived: sum of 3 quarters · filed 2026-08-04 | $6.33M 10-K · filed 2026-03-04 | ||||
| 2025-09-30 | $1.79M 10-Q · filed 2025-11-04 | $3.36M derived: sum of 2 quarters · filed 2026-08-04 | $4.62M 10-Q · filed 2025-11-04 | $5.93M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $1.57M 10-Q · filed 2026-08-04 | $2.83M 10-Q · filed 2026-08-04 | $4.14M derived: sum of 3 quarters · filed 2026-08-04 | $5.43M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $1.26M 10-Q · filed 2026-05-06 | $2.57M derived: sum of 2 quarters · filed 2026-05-06 | $3.86M derived: sum of 3 quarters · filed 2026-05-06 | $5.18M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $2.60M derived: sum of 2 quarters · filed 2026-03-04 | $3.92M derived: sum of 3 quarters · filed 2026-03-04 | $6.02M 10-K · filed 2026-03-04 | ||||
| 2024-09-30 | $1.29M 10-Q · filed 2025-11-04 | $2.61M derived: sum of 2 quarters · filed 2025-11-04 | $4.70M 10-Q · filed 2025-11-04 | $5.86M derived: sum of 4 quarters · filed 2025-11-04 | ||||
| 2024-06-30 | $1.32M 10-Q · filed 2025-08-06 | $3.41M 10-Q · filed 2025-08-06 | $4.57M derived: sum of 3 quarters · filed 2025-08-06 | $5.81M derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | $2.10M 10-Q · filed 2025-05-07 | $3.25M derived: sum of 2 quarters · filed 2025-05-07 | $4.50M derived: sum of 3 quarters · filed 2025-05-07 | $5.86M derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $2.40M derived: sum of 2 quarters · filed 2025-03-04 | $3.77M derived: sum of 3 quarters · filed 2025-03-04 | $4.96M 10-K · filed 2025-03-04 | ||||
| 2023-09-30 | $1.24M 10-Q · filed 2024-10-31 | $2.61M derived: sum of 2 quarters · filed 2024-10-31 | $3.80M 10-Q · filed 2024-10-31 | $5.08M derived: sum of 4 quarters · filed 2024-10-31 | ||||
| 2023-06-30 | $1.36M 10-Q · filed 2024-08-07 | $2.56M 10-Q · filed 2024-08-07 | $3.84M derived: sum of 3 quarters · filed 2024-08-07 | $5.06M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | $1.19M 10-Q · filed 2024-05-08 | $2.47M derived: sum of 2 quarters · filed 2024-05-08 | $3.70M derived: sum of 3 quarters · filed 2024-05-08 | $4.94M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $2.50M derived: sum of 2 quarters · filed 2024-03-06 | $3.75M derived: sum of 3 quarters · filed 2024-03-06 | $4.83M 10-K · filed 2024-03-06 | ||||
| 2022-09-30 | $1.22M 10-Q · filed 2023-11-08 | $2.47M derived: sum of 2 quarters · filed 2023-11-08 | $3.55M 10-Q · filed 2023-11-08 | $4.59M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $1.25M 10-Q · filed 2023-08-09 | $2.32M 10-Q · filed 2023-08-09 | $3.37M derived: sum of 3 quarters · filed 2023-08-09 | $4.36M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $1.08M 10-Q · filed 2023-05-10 | $2.12M derived: sum of 2 quarters · filed 2023-05-10 | $3.12M derived: sum of 3 quarters · filed 2023-05-10 | $4.12M derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $2.04M derived: sum of 2 quarters · filed 2023-03-08 | $3.04M derived: sum of 3 quarters · filed 2023-03-08 | $3.83M 10-K · filed 2023-03-08 | ||||
| 2021-09-30 | $996.00K 10-Q · filed 2022-11-02 | $2.00M derived: sum of 2 quarters · filed 2022-11-02 | $2.79M 10-Q · filed 2022-11-02 | $3.66M derived: sum of 4 quarters · filed 2022-11-02 | ||||
| 2021-06-30 | $1.00M 10-Q · filed 2022-08-10 | $1.79M 10-Q · filed 2022-08-10 | $2.66M derived: sum of 3 quarters · filed 2022-08-10 | $3.50M derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | $787.00K 10-Q · filed 2022-05-12 | $824.00K 10-Q · filed 2021-05-06 | $1.66M derived: sum of 2 quarters · filed 2022-05-12 | $2.50M derived: sum of 3 quarters · filed 2022-05-12 | $3.39M derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $870.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $1.71M derived: sum of 2 quarters · filed 2022-03-14 | $2.61M derived: sum of 3 quarters · filed 2022-03-14 | $3.42M 10-K · filed 2022-03-14 | $3.73M 10-K · filed 2021-03-12 | |||
| 2020-09-30 | $841.00K 10-Q · filed 2021-11-03 | $880.00K 10-Q · filed 2020-11-04 | $1.74M derived: sum of 2 quarters · filed 2021-11-03 | $2.54M 10-Q · filed 2021-11-03 | $2.74M 10-Q · filed 2020-11-04 | $3.79M derived: sum of 4 quarters · filed 2021-11-03 | ||
| 2020-06-30 | $895.00K 10-Q · filed 2021-08-03 | $942.00K 10-Q · filed 2020-08-06 | $1.70M 10-Q · filed 2021-08-03 | $1.86M 10-Q · filed 2020-08-06 | $2.95M derived: sum of 3 quarters · filed 2021-08-03 | $4.00M derived: sum of 4 quarters · filed 2021-08-03 | ||
| 2020-03-31 | $919.00K 10-Q · filed 2021-05-06 | $2.06M derived: sum of 2 quarters · filed 2021-05-06 | $3.10M derived: sum of 3 quarters · filed 2021-05-06 | $4.17M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $2.18M derived: sum of 2 quarters · filed 2021-03-12 | $3.25M derived: sum of 3 quarters · filed 2021-03-12 | $4.42M 10-K · filed 2021-03-12 | ||||
| 2019-09-30 | $1.04M 10-Q · filed 2020-11-04 | $2.11M derived: sum of 2 quarters · filed 2020-11-04 | $3.28M 10-Q · filed 2020-11-04 | $4.56M derived: sum of 4 quarters · filed 2020-11-04 | ||||
| 2019-06-30 | $1.07M 10-Q · filed 2020-08-06 | $2.24M 10-Q · filed 2020-08-06 | $3.51M derived: sum of 3 quarters · filed 2020-08-06 | $4.86M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $1.17M 10-Q · filed 2020-05-18 | $2.44M derived: sum of 2 quarters · filed 2020-05-18 | $3.79M derived: sum of 3 quarters · filed 2020-05-18 | $5.21M derived: sum of 4 quarters · filed 2020-05-18 | ||||
| 2018-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $2.63M derived: sum of 2 quarters · filed 2020-03-10 | $4.04M derived: sum of 3 quarters · filed 2020-03-10 | $5.48M 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | $1.35M 10-Q · filed 2019-11-12 | $2.76M derived: sum of 2 quarters · filed 2019-11-12 | $4.20M 10-Q · filed 2019-11-12 | $5.66M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $1.41M 10-Q · filed 2019-08-07 | $2.85M 10-Q · filed 2019-08-07 | $4.31M derived: sum of 3 quarters · filed 2019-08-07 | $5.35M derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | $1.44M 10-Q · filed 2019-05-09 | $2.89M derived: sum of 2 quarters · filed 2019-05-09 | $3.93M derived: sum of 3 quarters · filed 2019-05-09 | $4.78M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-30 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $2.49M derived: sum of 2 quarters · filed 2019-03-07 | $3.34M derived: sum of 3 quarters · filed 2019-03-07 | $4.01M 10-K · filed 2019-03-07 | $4.01M 10-K · filed 2018-03-15 | |||
| 2017-09-30 | $1.04M 10-Q · filed 2018-11-07 | $1.04M 10-Q · filed 2017-11-09 | $1.89M derived: sum of 2 quarters · filed 2018-11-07 | $2.55M 10-Q · filed 2018-11-07 | $2.55M 10-Q · filed 2017-11-09 | $3.09M derived: sum of 4 quarters · filed 2018-11-07 | ||
| 2017-07-01 | $850.00K 10-Q · filed 2018-08-09 | $849.96K 10-Q · filed 2017-08-10 | $1.51M 10-Q · filed 2018-08-09 | $1.51M 10-Q · filed 2017-08-10 | $2.05M derived: sum of 3 quarters · filed 2018-08-09 | $2.82M derived: sum of 4 quarters · filed 2018-08-09 | ||
| 2017-04-01 | $664.00K 10-Q · filed 2018-05-10 | $664.19K 10-Q · filed 2017-05-11 | $1.20M derived: sum of 2 quarters · filed 2018-05-10 | $1.97M derived: sum of 3 quarters · filed 2018-05-10 | $2.72M derived: sum of 4 quarters · filed 2018-05-10 | |||
| 2016-12-31 | $534.17K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $1.31M derived: sum of 2 quarters · filed 2018-03-15 | $2.06M derived: sum of 3 quarters · filed 2018-03-15 | $2.52M 10-K · filed 2018-03-15 | ||||
| 2016-10-01 | $772.80K 10-Q · filed 2017-11-09 | $1.52M derived: sum of 2 quarters · filed 2017-11-09 | $1.99M 10-Q · filed 2017-11-09 | |||||
| 2016-07-02 | $751.73K 10-Q · filed 2017-08-10 | $1.22M 10-Q · filed 2017-08-10 | ||||||
| 2016-04-02 | $464.07K 10-Q · filed 2017-05-11 | |||||||
| 2016-01-02 | $891.60K 10-K · filed 2018-03-15 | |||||||
| 2015-10-03 | $188.69K 10-Q · filed 2016-11-10 | $364.10K derived: sum of 2 quarters · filed 2016-11-10 | $485.19K 10-Q · filed 2016-11-10 | |||||
| 2015-07-04 | $175.41K 10-Q · filed 2016-08-11 | $296.50K 10-Q · filed 2016-08-11 | ||||||
| 2015-04-04 | $121.09K 10-Q · filed 2016-05-12 | |||||||
| 2015-01-03 | $513.67K 10-K · filed 2017-03-16 | $514.00K 10-K · filed 2015-03-19 | ||||||
| 2013-12-28 | $134.04K 10-K · filed 2016-03-17 | $134.00K 10-K · filed 2014-03-27 | ||||||
| 2012-12-29 | $142.00K 10-K · filed 2014-03-27 | $141.57K 10-K · filed 2013-03-29 | ||||||
| 2011-12-31 | $96.79K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |